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INTRODUCTION
The alarming increase in the incidence
and impact of obesity in Australia requires
urgent national focus at all levels of gov-
ernment and the community. The rea-
son for the call to action has been due
to the realization of the enormity of
the health issues of being overweight or
obese. There is clearly increased risk of
metabolic disease, cardiovascular compli-
cations and premature death. The predic-
tions outlined in a Victorian Government
report suggest increases in the preva-
lence of being overweight or obese of
between 0.4 and 0.8%, respectively per
year. From the levels in 1995 in which 65%
of adult males and 50% of adult females
were classified as overweight or obese, we
now expect levels to increase to 83% of
adult males and 75% of females by 2025
(Haby and Marwick, 2008). Thus, being
overweight or obese will become very
much the “norm” for Australians unless
this issue is addressed with appropri-
ate evidence based allocation of resources
for prevention, reduction and mitigation.
Importantly, we must clearly understand
and act on the short term and long term
impact on the health and well-being of
the individual of being overweight or
obese. The early consequences of obesity
involve a range of metabolic changes that
have been grouped together to define the
“metabolic syndrome” (Cameron et al.,
2009a). These include dyslipidaemia and
changes to metabolic homeostasis includ-
ing insulin resistance which is the primary
feature of type 2 diabetes. The progression
from obesity to metabolic dysfunction to
diabetes ultimately occurs unless there
are significant interventions. However, the
real danger lies in the long term effect
of obesity related metabolic disease on
cardiovascular risk associated with greater
rates of atherosclerosis, hypertension, vas-
cular disease and cardiovascular mortal-
ity. There is also a considerable alteration
in the quality of life related to public
stigma, reduced mobility, higher levels of
unemployment and psychological seque-
lae including depression. Thus, the pur-
pose of the current review is to bring
together the latest research on the health
complications of obesity as it becomes
the dominant driver for the health sector
and a dominant financial burden for the
community.
THE METABOLIC CONSEQUENCES OF
OBESITY FOR HEALTH
There is very strong evidence for the
causative association between obesity and
metabolic disease including dyslipidaemia,
insulin resistance and the development of
type 2 diabetes although the mechanisms
are not fully understood. The dyslipi-
daemia associated with obesity includes
elevated triglycerides (Howard et al., 2003)
higher levels of specific forms of low den-
sity lipoprotein (LDL) particles (Williams
and Krauss, 1997) and reduced high den-
sity lipoprotein (HDL) levels and these
changes are all known to be atherogenic
(Howard et al., 2003). Being overweight
incurs a 2 ormore fold elevated risk of high
triglycerides, reduced HDL and metabolic
syndrome. Being obese adds a staggering
4 fold increased risk of diabetes (Cameron
et al., 2009b). The 5 year follow up of the
AusDiab population study in 2005 indi-
cates that the incidence of impaired glu-
cose tolerance, impaired fasting glucose or
type 2 diabetes in Australia in 2005 was
14% (Williams et al., 2010). Amore alarm-
ing statistic is that predicted future adult
levels of diabetes (from 2010 to 2030) will
increase by 69% in developing countries
and by 20% in developed countries (Shaw
et al., 2010). The latter rise parallels quite
closely the rate of increase in obesity in the
Australian community which is expected
given their well-established association.
Indigenous Australians have a higher
rate of diabetes as well as high rates of
dyslipidaemia and metabolic syndrome. A
recent population study in the Northern
Territory shows that almost one-third of
those aged over 35 and over half of those
over 55 years have diabetes (O’Dea et al.,
2008). Clearly there needs to be consider-
able extra effort in such groups if we are to
“bridge the gaps.”
LONG TERM IMPACT OF OBESITY ON
HEALTH ANDWELL-BEING
HYPERTENSION AND ISCHAEMIC HEART
DISEASE
The cardiovascular consequences of obe-
sity are arguably the most important due
to the high risk that being overweight or
obese incurs particularly in men. While
30–40% of the elevated triglyceride and
reduced HDL are due to obesity in women,
this is associated with only 13% ofmyocar-
dial infarction. For the men the reverse is
true. Only 16–17% of the lipid changes are
due to obesity but this has been attributed
to a 32% greater incidence of myocardial
infarction (Cameron et al., 2009b).
The impact of obesity is broader than
the common view that the associated
dyslipidaemia is a major cause of coro-
nary artery disease. The vast majority
of new cases of hypertension are related
to obesity (Garrison et al., 1987). The
mechanism of the hypertension has been
extensively studied particularly in ani-
mal models. Central actions of leptin
in the hypothalamus result in increased
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sympathetic activity to peripheral blood
vessels and particularly to the kidney caus-
ing elevated blood pressure (Head et al.,
2014). Obesity characterized by increased
fat and also lean body mass results in
increased oxygen demand, increased blood
volume, cardiac output, stroke volume,
and eccentric cardiac hypertrophy (Hall
et al., 2002). Together with concentric
cardiac hypertrophy from elevated blood
pressure, coronary artery disease leads
to both systolic and diastolic dysfunc-
tion (Lawrence and Kopelman, 2004).
Prolonged obesity and hypertension may
also contribute to glomerular hyperten-
sion, hyper-filtration and loss of renal
function and increased salt sensitivity
(Hall et al., 2003). High circulating levels
of leptin result in leptin resistance and loss
of appetite suppression while the central
pressor actions are amplified (Head et al.,
2014).
While hypertension is usually asymp-
tomatic, increased blood pressure is asso-
ciated with increased risk of stroke,
myocardial infarction and renal failure.
A 20 year follow up of over 15000
subjects found that compared to normal
subjects with BMI less than 25, obese sub-
jects with BMI>30 had a 1.5–2.5 fold risk
of coronary heart disease (death or hos-
pitalization), heart failure, stroke, venous
thromboembolism, and atrial fibrillation
(Murphy et al., 2006).
SLEEP AND ACTIVITY DISORDERED
BREATHING
Breathlessness upon minor exercise is
common in obesity due to the presence
of abdominal and chest deposits of fat that
hinder breathing by limiting the excur-
sion of the diaphragm (Lawrence and
Kopelman, 2004). However, the more
serious impact upon respiration comes
during recumbent sleep when increased
fat and soft tissue in the throat obstruct
the airway which is known as obstruc-
tive sleep apnoea (OSA) (Lawrence and
Kopelman, 2004). This results in eleva-
tion of nocturnal blood pressure and is
strongly linked to an increased risk of
developing hypertension. Half of those
with morbid obesity have OSA and half
of the patients with OSA have hyper-
tension (Silverberg et al., 1995). The
mechanism appears to involve central acti-
vation of the chemoreflex and increased
sympathetic activity (Narkiewicz and
Somers, 1999). Consequences of OSA
include daytime sleepiness, increased risk
of traffic accidents, increased risk of stroke
and pulmonary hypertension (Lawrence
and Kopelman, 2004).
VASCULAR DISEASE
The complications associated with obesity
and in particular when type 2 dia-
betes develops, include peripheral vascu-
lar disease, coronary artery disease and
endothelial dysfunction. While it is dif-
ficult to separate the influence of obe-
sity from the other risk factors, studies
have shown that obesity is independently
associated with endothelial dysfunction
(Avogaro and de Kreutzenberg, 2005).
Mechanisms may involve adipokines and
cytokine induced oxidative stress and low
level inflammation. Vascular markers of
inflammation such as plasminogen acti-
vation inhibitor, fibrinogen and c-reactive
protein are also positively correlated with
obesity (Lawrence and Kopelman, 2004).
Thus, it is not surprising that obe-
sity and the ensuing dyslidipdaemia are
associated with deep venous thrombosis,
pulmonary embolism and atherosclerotic
arterial disease (Lawrence and Kopelman,
2004).
GOUT, ARTHRITIS, AND GALL STONES
Gout and hyperuricemia is a growing
health problem particularly in affluent
countries such as Australia where it
is commonly associated with metabolic
syndrome, type 2 diabetes, obesity and
hypertension (Robinson et al., 2012).
Obesity is strongly associated with gouty
arthritis but also with osteoarthritis. More
recently it has been realized that obesity is
also associated with rheumatoid arthritis
(Stavropoulos-Kalinoglou et al., 2011).
CANCER
While the mechanisms relating obesity to
cancer are unclear due to the confounding
effects of metabolic changes, dyslipi-
daemias, growth factors such as insulin-
like growth factor and changes to hormone
metabolism, there is a definite association
for specific cancers. A meta-analysis has
estimated that obesity accounts for 5%
of all cancers but particularly for cancer
of the endometrium (39%), the kidney
(25%), and gallbladder (25%) (Bergstrom
et al., 2001).
COMPLICATIONS IN SURGERY
Due to the more likely presence of coro-
nary artery disease and hypertension, the
obese patient is at greater risk of numerous
medical issues that can occur during
and subsequent to surgery but which
can be minimized with appropriate pre-
cautions and monitoring (Choban and
Flancbaum, 1997). Obese surgical patients
have increased risk of deep vein throm-
bosis and surgical site infection. There
is also a well-known obesity paradox
where there is better survival of the obese
patient after myocardial infarct and coro-
nary bypass surgery that is independent of
age, sex, medical therapy, and other factors
(Amundson et al., 2010).
MANAGING THE PSYCHOLOGICAL
AND SOCIAL IMPACT OF OBESITY
More and more there is realization of the
impact of the stigma of obesity on individ-
uals (O’Brien et al., 2013). This perhaps is
surprising given the increasing prevalence
of obesity. Anti-obesity discrimination can
occur even among health professionals and
obesity researchers. The causes are many
but the perception of lack of personal
control, gluttony, and laziness as well as
the promotion of distortedly thin body
image aspirations all play a part (O’Brien
et al., 2013). A recent study demonstrated
that the level of anti-fat prejudice along
with other prejudicial attitudes manifested
resulted in obesity discrimination. People
with obesity are less likely to be success-
ful at job interviews and once employed
are assigned less desirable tasks and receive
lower salaries than colleagues (O’Brien
et al., 2013).
Obesity is often associated with a range
of psychological disturbances including
anxiety, depression, poor body image,
binge eating disorders which are exacer-
bated by social stigma and chronic dis-
eases such as arthritic pain and functional
disability. Depression is highest in those
with disordered eating or those with symp-
toms of bodily pain. Overall quality of
life is severely reduced particularly in the
morbidly obese patients (Dixon, 2010).
While psychological impact and quality
of life is a major problem for the indi-
vidual and for society, it is a particularly
difficult area to research the underlying
mechanisms due to the many interacting
factors.
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The reality is that the maintenance of
body weight is so strongly defended by
inbuilt physiological processes that only
an extremely small percentage of the
population can sustain weight reduction in
the long term. On the other hand, storage
of excess calories occurs readily, surrep-
titiously and without immediate conse-
quences such that during adulthood the
weight gain appears almost inevitable and
is not at all gluttony or lack of self-
control. Obesity needs to be considered
as a chronic medical disease state requir-
ing a multi-step approach to weight man-
agement as suggested by Kushner (2014).
Simply telling a patient to lose weight is
not a long term strategy and consider-
able investment in understanding the driv-
ing factors including social issues, lifestyle,
food marketing strategies and the like is
necessary. At the same time there needs to
be a much greater acceptance of the bio-
logical causes and investment in research
to develop effective therapies in addi-
tion to those currently available (Kushner,
2014). While gastric surgical techniques
have been shown to have long term weight
reduction effectiveness, it is abundantly
clear that this is not a solution for more
than a small number of the huge per-
centage of the population that are affected
(Kushner, 2014).
CONCLUSIONS
The alarming increase in the propor-
tion of the Australian community and
particularly the indigenous community
that are overweight, obese or morbidly
obese must be considered as one of most
pressing health issues of our time. The
adverse changes in metabolic homeosta-
sis, lipidmetabolism, pro-thrombotic state
and the development of diabetes coalesce
to exponentially increase cardiovascular
risk. Thus, obesity is a major contrib-
utor to cardiovascular disease, hyperten-
sion, myocardial infarcts and stroke. For
the individual, the decreased mobility, dis-
comfort, lower limb and joint pain, social
standing, and mental health status result
in a serious deterioration of quality of
life particularly for those most affected.
Dieting is obviously the most effective
strategy for being overweight or obese
but is difficult to maintain in the long-
term without additional pharmacological
or surgical interventions. It is important
to also recognize that obesity is a disease
state and that negative social attitudes par-
ticularly from health professionals may
be driving patients away from seeking
appropriate professional help.
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